Anemias in chronic obstructive pulmonary disease


Cite item

Full Text

Abstract

According to different studies, anemia occurs in 8—33% of patients with chronic obstructive pulmonary disease (COPD). The paper describes the most important various causes of anemia in COPD, such as systemic inflammation and endocrine disorders, the use of some medications (theophylline, angiotensin-converting enzyme inhibitors), frequent COPD exacerbations, and long-term oxygen therapy. Lower hemoglobin levels in COPD patients are accompanied by increased shortness of breath, reduced exercise tolerance, and lower quality of life. Furthermore, some investigations have shown that anemia is an independent predictor of death in patients with COPD. In spite of the fact that anemia may be successfully in these patients, the evidence suggesting the importance of its impact on the prognosis of COPD is limited.

References

  1. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Белевский А.С., Лещенко И.В., Мещерякова Н.Н., Овчаренко С.И., Шмелев Е.И. Российское респираторное общество. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни легких. Пульмонология. 2014;3:15-54.
  2. Белевский А.С. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких (пересмотр 2011 г.). Пер. с англ. М.: Российское респираторное общество; 2012.
  3. Авдеев С.Н. Хроническая обструктивная болезнь легких: обострения. Пульмонология. 2013;3:5-19.
  4. Будневский А.В., Овсянников Е.С., Чернов А.В., Дробышева Е.С. Диагностическое значение биомаркеров системного воспаления при хронической обструктивной болезни легких. Клиническая медицина. 2014;92(9):16-21.
  5. Будневский А.В., Овсянников Е.С., Чернов А.В., Дробышева Е.С. Биомаркеры как предикторы исходов хронической обструктивной болезни легких (обзор литературы). Молодой ученый. 2014;5(64):125-128.
  6. Провоторов В.М., Первеева И.М., Перфильева М.В., Овсянников Е.С. Качество жизни больных с хронической обструктивной болезнью легких и приобретенным андрогенодефицитом. Журнал теоретической и практической медицины. 2010;8(3):489.
  7. Barnes P, Celli B. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33:1165-1185. doi: 10.1183/09031936.00128008.
  8. World Health Organization. Nutritional anemias: report of a WHO scientific group. WHO Technical Report Series 405. Geneva: World Health Organization; 1968:1-37.
  9. Cote C, Zilberberg M, Mody S, Dordelly L, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923-929. doi: 10.1183/09031936.00137106.
  10. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest. 2005;127:825-829.
  11. Chambellan A, Chailleux E, Similowski T. Prognostic value of hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005;128(3):1201-1208. doi: 10.1378/chest.128.3.1201.
  12. John M, Lange A, Hoernig S, Witt C, Anker S. Prevalence of anemia in chronic obstructive pulmonary disease: Comparison to other chronic diseases. Int J Cardiol. 2006;111(3):365-370. doi: 10.1016/j.ijcard.2005.07.043.
  13. Portillo K, Belda J, Anton P, Casan P. High frequency of anemia in COPD patients admitted in a tertiary hospital. Rev Clin Esp. 2007;207:383-387.
  14. Halpern M, Zilberberg M, Schmier J, Lau E, Shorr A. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff. Resour Alloc. 2006;16(4):17.
  15. Shorr A, Doyle J, Stern L, Dolgitser M, Zilberberg M. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Cur Med Res Opin. 2008;24(4):1123-1130. doi: 10.1185/030079908x280699.
  16. Roy C. Anemia of Inflammation. Hematology. 2010;2010(1):276-280. doi: 10.1182/asheducation-2010.1.276.
  17. Gan W. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574-580. doi: 10.1136/thx.2003.019588.
  18. MacNee W. Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease. Proceed Am Thor Soci. 2005;2(1):50-60. doi: 10.1513/pats.200411-056sf.
  19. Tassiopoulos S, Kontos A, Konstantopoulos K, Hadzistavrou C, Vaiopoulos G, Aessopos A, Tassiopoulos T. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med. 2001;95(6):471-475. doi: 10.1053/rmed.2001.1070.
  20. Soler-Cataluña J, Martínez-García M, Serra P. Impacto multidimensional de las exacerbaciones de la EPOC. Archivos de Bronconeumología. 2010;46:12-19. doi: 10.1016/s0300-2896(10)70057-0.
  21. Sala E, Balaguer C, Villena C et al. Low Erythropoietin Plasma Levels during Exacerbations of COPD. Respiration. 2010;80(3):190-197. doi: 10.1159/000264604.
  22. Markoulaki D, Kostikas K, Papatheodorou G et al. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Int Med. 2011;22(1): 103-107. doi: 10.1016/j.ejim.2010.07.010.
  23. Tsantes A, Papadhimitriou S, Tassiopoulos S et al. Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease. Respir Med. 2004;98(11):1117-1123. doi: 10.1016/j.rmed.2004.04.002.
  24. Garcia-Pachon E, Padilla-Navas I. Red cell macrocytosis in COPD patients without respiratory insufficiency: A brief report. Respir Med. 2007;101(2):349-352. doi: 10.1016/j.rmed.2006.05.003.
  25. Andreas S. Neurohumoral Activation as a Link to Systemic Manifestations of Chronic Lung Disease. Chest. 2005;128(5):3618-3624. doi: 10.1378/chest.128.5.3618.
  26. Vlahakos D, Kosmas E, Dimopoulou I et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med. 1999;106(2):158-164. doi: 10.1016/s0002-9343(98)00390-8.
  27. Pham I, Andrivet P, Sediame S et al. Increased erythropoietin synthesis in patients with COLD or left heart failure is related to alterations in renal haemodynamics. Eur J Clin Invest. 2001;31(2): 103-109. doi: 10.1046/j.1365-2362.2001.00774.x.
  28. Casaburi R, Bhasin S, Cosentino L et al. Effects of Testosterone and Resistance Training in Men with Chronic Obstructive Pulmonary Disease. Am J Respir Crit CareMed. 2004;170(8):870-878. doi: 10.1164/rccm.200305-617oc.
  29. Ferrucci L, Maggio M, Bandinelli S et al. Low Testosterone Levels and the Risk of Anemia in Older Men and Women. Arch Intern Med. 2006;166(13):1380. doi: 10.1001/archinte.166.13.1380.
  30. Tsantes A, Tassiopoulos S, Papadhimitriou S et al. Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production. Eur J Clin Pharmacol. 2003;59(5-6):379-383. doi: 10.1007/s00228-003-0640-0.
  31. Celli B, Cote C, Marin J et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. New Engl J Med. 2004;350(10): 1005-1012. doi: 10.1056/nejmoa021322.
  32. Lima D, Coleta K, Tanni S, Silveira L, Godoy I, Godoy I. Potentially modifiable predictors of mortality in patients treated with long-term oxygen therapy. Respir Med. 2011;105(3):470-476. doi: 10.1016/j.rmed.2010.08.012.
  33. Schonhofer B, Bohrer H, Kohler D. Importance of blood transfusion in anemic patients with COPD and unsuccessful weaning from respirator. Med Klin. 1999;Suppl 1:108-110.
  34. Schonhofer B, Wenzel M, Geibel M, Kohler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med. 1998; 26(11):1824-1828. doi: 10.1097/00003246-199811000-00022.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies